Dr Edward O'Neill

Topics discussed include (00:00:30) early interest in science, PhD studies in chemistry at the University of Sydney, undergraduate studies and government work in Australia, interest in immunology; (00:05:13) current interest and work at Oxford, including an injected targeted therapy for tumours; (00:06:45) first awareness of COVID-19, changes to work including remote working, life under lockdown conditions; (00:14:25) Oxford vaccine trial involvement; (00:21:17) eligibility criteria to participate for the vaccine trial; (00:23:18) receiving the first trial dose on 23rd April 2020, including health screening, media involvement; (00:37:41) hoax stories and disinformation around the trial, interviews with U.K. and Australian media; (00:45:31) work of the Jenner vaccine team; (00:46:21) interest in vaccine development; (00:48:24) media interviews, social media use; (00:54:22) follow-up procedure after receiving the vaccine, including unblinding stage; (01:05:20) volunteering for future clinical trials; (01:10:07) disinformation and vaccine hesitancy; (01:15:14) return to work, uncertainty around funding and status, lasting legacy of COVID-19 vaccines. Note: the following sections of audio are redacted (00:23:46) to (00:23:50); (00:34:53) to (00:35:00).